Kite Pharma, Inc. Operating Income
Kite Pharma, Inc. reported Operating Income of -$101.92 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2017-08-08
- Kite Pharma, Inc. operating income (loss) for the quarter ending 2017-06-30 was -$101.92M.
- Kite Pharma, Inc. operating income (loss) for the quarter ending 2017-03-31 was -$91.91M.
- Kite Pharma, Inc. operating income (loss) for the quarter ending 2016-12-31 was -$85.80M.
- Kite Pharma, Inc. operating income (loss) for the quarter ending 2016-09-30 was -$75.15M.
- Kite Pharma, Inc. operating income (loss) for fiscal 2016 was -$273.19M.
- Kite Pharma, Inc. operating income (loss) for fiscal 2015 was -$103.95M.
- Kite Pharma, Inc. operating income (loss) for fiscal 2014 was -$36.66M.
- Kite Pharma, Inc. operating income (loss) for fiscal 2013 was -$6.43M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | -$101.92M 10-Q · filed 2017-08-08 | -$193.35M 10-Q · filed 2017-08-08 | -$279.63M derived: sum of 3 quarters · filed 2017-08-08 | -$354.77M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2017-03-31 | -$91.91M 10-Q · filed 2017-05-08 | -$177.71M derived: sum of 2 quarters · filed 2017-05-08 | -$252.85M derived: sum of 3 quarters · filed 2017-05-08 | -$319.13M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-12-31 | -$85.80M 10-K · filed 2017-02-28 | -$160.94M derived: sum of 2 quarters · filed 2017-02-28 | -$227.22M derived: sum of 3 quarters · filed 2017-08-08 | -$273.19M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | -$75.15M 10-K · filed 2017-02-28 | -$74.95M 10-Q · filed 2016-11-09 | -$141.42M derived: sum of 2 quarters · filed 2017-08-08 | -$186.82M 10-Q · filed 2016-11-09 | -$225.61M derived: sum of 4 quarters · filed 2017-08-08 | ||
| 2016-06-30 | -$66.27M 10-Q · filed 2017-08-08 | -$66.08M 10-Q · filed 2016-08-08 | -$112.24M 10-Q · filed 2017-08-08 | -$111.86M 10-Q · filed 2016-08-08 | -$150.47M derived: sum of 3 quarters · filed 2017-08-08 | -$178.43M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | -$45.97M 10-Q · filed 2017-05-08 | -$45.78M 10-Q · filed 2016-05-09 | -$84.19M derived: sum of 2 quarters · filed 2017-05-08 | -$112.16M derived: sum of 3 quarters · filed 2017-05-08 | -$134.30M derived: sum of 4 quarters · filed 2017-05-08 | ||
| 2015-12-31 | -$38.22M 10-K · filed 2017-02-28 | -$38.03M 10-K · filed 2016-02-29 | -$66.19M derived: sum of 2 quarters · filed 2017-02-28 | -$88.33M derived: sum of 3 quarters · filed 2017-02-28 | -$103.95M 10-K · filed 2017-02-28 | -$103.32M 10-K · filed 2016-02-29 | |
| 2015-09-30 | -$27.96M 10-K · filed 2017-02-28 | -$27.77M 10-Q · filed 2015-11-12 | -$50.11M derived: sum of 2 quarters · filed 2017-02-28 | -$65.28M 10-Q · filed 2016-11-09 | -$78.98M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | -$22.15M 10-K · filed 2017-02-28 | -$21.96M 10-Q · filed 2015-08-10 | -$37.51M 10-Q · filed 2016-08-08 | -$51.02M derived: sum of 3 quarters · filed 2017-02-28 | -$60.12M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | -$15.62M 10-K · filed 2017-02-28 | -$15.55M 10-Q · filed 2015-05-15 | -$28.87M derived: sum of 2 quarters · filed 2017-02-28 | -$37.97M derived: sum of 3 quarters · filed 2017-02-28 | -$49.11M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | -$13.26M 10-K · filed 2016-02-29 | -$22.36M derived: sum of 2 quarters · filed 2016-02-29 | -$33.50M derived: sum of 3 quarters · filed 2016-02-29 | -$36.66M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | -$9.10M 10-K · filed 2016-02-29 | -$20.24M derived: sum of 2 quarters · filed 2016-02-29 | -$23.40M 10-Q · filed 2015-11-12 | -$25.80M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | -$11.14M 10-K · filed 2016-02-29 | -$14.30M 10-Q · filed 2015-08-10 | -$16.70M derived: sum of 3 quarters · filed 2016-02-29 | -$18.21M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$3.16M 10-K · filed 2016-02-29 | -$5.56M derived: sum of 2 quarters · filed 2016-02-29 | -$7.07M derived: sum of 3 quarters · filed 2016-02-29 | -$8.50M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$2.40M 10-K · filed 2015-03-26 | -$3.90M derived: sum of 2 quarters · filed 2015-03-26 | -$5.34M derived: sum of 3 quarters · filed 2015-03-26 | -$6.43M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$1.51M 10-K · filed 2015-03-26 | -$2.94M derived: sum of 2 quarters · filed 2015-03-26 | -$4.03M 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | -$1.43M 10-K · filed 2015-03-26 | -$2.52M 10-Q · filed 2014-08-14 | |||||
| 2013-03-31 | -$1.09M 10-K · filed 2015-03-26 | ||||||
| 2012-12-31 | -$2.58M 10-K · filed 2015-03-26 |